Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma

1. Mateos, M.-V.
2. Rigaudeau, S.
3. Basu, S.
4. Spicka, I.
5. Schots, R.
6. Wrobel, T.
7. Cook, G.
8. Beksac, M.
9. Gries, K.S.
10. Kudva, A.
11. Tromp, B.
12. Van Rampelbergh, R.
13. Pei, H.
14. Wroblewski, S.
15. Carson, R.
16. Delioukina, M.
17. White, D.